Covered recipient · General Payments record
MICHAEL E WEINBLATT
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$313,349.34
- Reported across 254 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,950.00 | 3 |
| Food and Beverage | $294.44 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $887.90 | 2 |
| Roche Products Limited | $575.00 | 1 |
| Gilead Sciences, Inc. | $500.00 | 1 |
| UCB, Inc. | $178.82 | 2 |
| Sandoz Inc. | $54.37 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.08 | 1 |
| PFIZER INC. | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Eli Lilly and Company | $12.90 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135187959 | CMS |
| Eli Lilly and Company | $875.00 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135172284 | CMS |
| Gilead Sciences, Inc. | $500.00 | 06/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133599969 | CMS |
| Novartis Pharmaceuticals Corporation | $35.08 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087418142 | CMS |
| PFIZER INC. | $13.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131677553 | CMS |
| Roche Products Limited | $575.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133072111 | CMS |
| Sandoz Inc. | $14.39 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089374710 | CMS |
| Sandoz Inc. | $18.13 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089374764 | CMS |
| Sandoz Inc. | $21.85 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089374774 | CMS |
| UCB, Inc. | $134.95 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143155378 | CMS |
| UCB, Inc. | $43.87 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143155382 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.